Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report) shares were down 5.5% during trading on Tuesday . The stock traded as low as $7.9152 and last traded at $7.9152. Approximately 500 shares traded hands during mid-day trading, a decline of 35% from the average daily volume of 771 shares. The stock had previously closed at $8.3750.
Oxford BioMedica Price Performance
The company has a 50-day moving average of $8.12 and a 200 day moving average of $9.02.
Oxford BioMedica Company Profile
Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. The company specializes in the development, manufacturing and commercialization of lentiviral vector delivery systems for use in treating serious diseases. Its proprietary LentiVector® platform underpins both in-house development programs and third-party collaborations, enabling the stable integration of therapeutic genes into target cells.
In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications.
See Also
- Five stocks we like better than Oxford BioMedica
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
- Palo Alto Networks Accelerates Growth 31% on AI Demand
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
